Selank represents one of the few peptide compounds studied simultaneously for both anxiolytic and cognitive-enhancing properties. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, this tuftsin-derivative has been investigated in preclinical and clinical settings, approved in Russia as an anxiolytic nasal spray, and continues to attract research interest for its unique non-sedating pharmacological profile.

Structure and Origin

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its core tetrapeptide (Thr-Lys-Pro-Arg) is tuftsin, an endogenous immunostimulatory peptide derived from the Fc region of IgG. The C-terminal Pro-Gly-Pro extension enhances metabolic stability and CNS bioavailability. This design rationale — building on an endogenous peptide scaffold — gives Selank a fundamentally different pharmacological basis from synthetic small-molecule anxiolytics.

Anxiolytic Research

In elevated plus maze, light-dark box, and social interaction tests in rodents, Selank produced anxiolytic effects at doses of 250-300 mcg/kg without the sedation, muscle relaxation, or cognitive impairment associated with benzodiazepines. The mechanism appears to involve modulation of GABAergic neurotransmission — Selank enhances the inhibitory effects of GABA in the CNS — alongside serotonergic and enkephalinergic pathway interactions (Seredenin et al., 2002; PMID: 12596521).

Cognitive and Nootropic Effects

Selank enhances learning and memory in multiple rodent paradigms including passive avoidance, Morris water maze, and conditioned reflex tasks. A key molecular mechanism identified is upregulation of BDNF in the hippocampus — the brain region central to memory consolidation. Selank also modulates expression of genes involved in synaptic plasticity, including those encoding glutamate receptor subunits and neurotrophic factors (Inozemtseva et al., 2008).

Immunomodulatory Properties

Given its tuftsin core, Selank retains immunomodulatory activity. It enhances IL-6 expression, modulates T-helper cell balance, and has been studied for antiviral activity — particularly against influenza strains. This dual CNS-immune profile is unusual among peptide compounds and reflects the neuroimmune crosstalk that is increasingly recognized in biomedical research.

Research-Grade Selank

Selank is available in 11mg lyophilized vials at researchvials.com.

References

  1. Seredenin SB, et al. Anxiolytic effect of Selank. Bull Exp Biol Med. 2002;133(5):456-8. PMID: 12360348
  2. Kozlovskii II, et al. The role of the GABA system in the mechanism of action of Selank. Bull Exp Biol Med. 2003;136(5):468-70. PMID: 14968162

Frequently Asked Questions

What is Selank?

Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with an added Gly-Pro extension. Developed at the Russian Academy of Sciences, it has been studied for anxiolytic, nootropic, and immunomodulatory properties.

How does Selank compare to benzodiazepines in research?

Preclinical studies show Selank produces anxiolytic effects comparable to low-dose benzodiazepines without sedation, cognitive impairment, muscle relaxation, or dependence potential — making it a distinct pharmacological profile from GABAergic anxiolytics.

What is the connection between Selank and BDNF?

Selank has been shown to upregulate brain-derived neurotrophic factor (BDNF) expression in rodent hippocampus, which may underlie its observed pro-cognitive and anxiolytic effects. BDNF is critical for synaptic plasticity and neuronal survival.

Continue Reading

Research Reference

Peptides and Cancer (Part 1): How Cancer Begins and the Pathways Tumors Hijack

Plain-English research guide to cancer biology. Initiation vs promotion, the hallmarks of cancer, VE...

Research Reference

Peptides and Cancer (Part 2): Metastasis, Tumor Brakes, and the First Peptide Deep Dives

Plain-English research guide covering EMT and metastasis, tumor suppressors (p53, PTEN, BRCA), and d...

Research Reference

Peptides and Cancer (Part 3): GH Secretagogues, Risk, Washouts, and the Other Side

Plain-English research guide covering the GH secretagogue class (tesamorelin, CJC-1295, ipamorelin, ...

Research Reference

Peptide Syringe Compatibility: A Research-Use Reference for Co-Administration Chemistry

Research-use reference on which peptides can be drawn into the same syringe. Five compatibility fact...

Reference Manual

The Peptide Reference Manual: A Working Guide for Researchers

A 9,000-word working bench reference covering peptide biology, sourcing, reconstitution math, the tw...

Lab Protocol

How to Reconstitute SLU-PP-332: A Research Protocol for the Non-Peptide ERR Agonist

SLU-PP-332 is a small organic molecule, not a peptide — bacteriostatic water alone will not dissolve...

Protocol Reference

TRT Cream and HCG Timing in Clinical Research: When the Protocol Literature Says to Dose

When should research subjects on trans-scrotal testosterone replacement therapy apply cream, and whe...

Comparison

Epitalon vs Epitalon Amidate vs N-Acetyl Epitalon Amidate: A Researcher's Guide to the Three Forms

Comprehensive comparison of Epitalon (AEDG), Epitalon Amidate (AEDG-NH2), and N-Acetyl Epitalon Amid...

Peptide Deep Dive

Peptides Studied for Hepatic Function: A Research Reference

A research reference covering the peptides most commonly studied for hepatic endpoints — Tesamorelin...

Reference Map

Peptide Synergy & Conflict Map

A visual reference covering 18 widely-studied research compounds — what each one targets, which comb...

GLP Research

AOD-9604 vs Semaglutide: Metabolic Research Compared

Comparing AOD-9604 and semaglutide for metabolic research. Different mechanisms, evidence levels, an...

Education

Peptide Research Starter Guide for New Scientists

A beginner's guide to peptide research. From basic chemistry to lab setup, reconstitution protocols,...